Wearable Sensory Insole Technology Trialled for Recurrent Diabetic Foot Ulcer Prevention — What Clinicians Need to Know
247 Health News Editorial
·16 July 2026
·4 min read
·clinical-trialsA Johns Hopkins University-sponsored pilot trial is evaluating the Orpyx SI Sensory Insole System as an adjunct to standard care for preventing recurrent plantar diabetic foot ulcers in high-risk patients with peripheral neuropathy. The study targets a critical unmet need, given that ulcer recurrence rates reach 40% within one year of healing. Clinicians in endocrinology, podiatry, and vascular surgery should monitor this trial's findings closely.
Originally reported by ClinicalTrials.gov
References
- 1.Johns Hopkins University. (2025). Wearable insoles for recurrent diabetic ulcer prevention (NCT07674420). ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT07674420
- 2.Pop-Busui, R., Boulton, A. J. M., Feldman, E. L., Bril, V., Freeman, R., Malik, R. A., Sosenko, J. M., & Ziegler, D. (2017). Diabetic neuropathy: A position statement by the American Diabetes Association. Diabetes Care, 40(1), 136–154. https://doi.org/10.2337/dc16-2042
- 3.Armstrong, D. G., Boulton, A. J. M., & Bus, S. A. (2017). Diabetic foot ulcers and their recurrence. New England Journal of Medicine, 376(24), 2367–2375. https://doi.org/10.1056/NEJMra1615439
- 4.Boulton, A. J. M., Vileikyte, L., Ragnarson-Tennvall, G., & Apelqvist, J. (2005). The global burden of diabetic foot disease. The Lancet, 366(9498), 1719–1724. https://doi.org/10.1016/S0140-6736(05)67698-2
- 5.Najafi, B., Reeves, N. D., & Armstrong, D. G. (2019). Leveraging smart technologies to improve the management of diabetic foot ulcers and extend ulcer-free days in remission. Diabetes/Metabolism Research and Reviews, 35(4), e3158. https://doi.org/10.1002/dmrr.3158
- 6.Bus, S. A., Lavery, L. A., Monteiro-Soares, M., Rasmussen, A., Raspovic, A., Sacco, I. C. N., & van Netten, J. J. (2020). Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2019 update). Diabetes/Metabolism Research and Reviews, 36(S1), e3269. https://doi.org/10.1002/dmrr.3269
2
247 Health News Editorial
247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.
Related Articles
clinical-trials
Digital Health Platform vs Case Manager Support in Hypertension Management: Taiwan's 1,726-Participant Trial Signals a Shift in Blood Pressure Care Delivery
3 Aug 2026
clinical-trials
Phase II Trial: AI-Powered Wysa Chatbot vs Unmet Need — Digital Eating Disorder Prevention in At-Risk Adolescents
3 Aug 2026
clinical-trials
Pilot Trial Targets the Inpatient-to-Outpatient Gap: Digital Smoking Cessation Intervention for Persons With Serious Mental Illness — Key Findings for Clinicians
3 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service